A woman whose cancer has spread to her bones, back, pelvis and neck but has been denied a life-extending drug because she ...
MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million ...
AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback